3 week pause versus continued BTKi during vaccination (IMPROVE): a randomised, open-label, superiority trial.

Parry H., Cook J., Peckham N., Phillips N., Talbot G., Abhishek A., Duley L., Hodges M., Roberts T., Barber V., Francis A., Shields A., Hoogeboom R., Willett B., Scott S., Parry-Jones N., Eyre T., Hutchinson C., Wandroo F., Paneesha S., Murray D., Jenkins S., Moss P., Heartin E., Martinez-Calle N., Patten P.

Type

Conference paper

Publication Date

2025-01-01T00:00:00+00:00

Volume

206

Permalink Close